Mainz Biomed B.V. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Mainz Biomed B.V. | MYNZ - NASDAQ |
$4.00-$6.00 | $5.00 | $14.35 | 2 million | 11/4/2021 |
| Boustead Securities, LLC | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Terms Added 2021-10-28 | ||||||
Mainz Biomed B.V. Quote & Chart - Click for current quote - MYNZ
IPO Boutique aggregates information on public companies and private companies, such as "MYNZ" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Mainz Biomed B.V. (adapted from Mainz Biomed B.V. prospectus):
They are a molecular genetics cancer diagnostic company formed in 2021 to acquire PharmGenomics GmbH (“PharmGenomics“) with the purpose of commercializing their product portfolio in Europe and the United States.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a molecular genetics cancer diagnostic company formed in 2021 to acquire PharmGenomics GmbH (“PharmGenomics“) with the purpose of commercializing their product portfolio in Europe and the United States.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "MYNZ" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.